These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 7356882)
1. The kinetics of propranolol in hypothyroidism [proceedings]. Riddell JG; Neill JD; Kelly JG; McDevitt DG Br J Clin Pharmacol; 1980 Jan; 9(1):121P. PubMed ID: 7356882 [No Abstract] [Full Text] [Related]
2. Effects of thyroid dysfunction on propranolol kinetics. Riddell JG; Neill JD; Kelly JG; McDevitt DG Clin Pharmacol Ther; 1980 Nov; 28(5):565-74. PubMed ID: 7438675 [TBL] [Abstract][Full Text] [Related]
3. Studies of the effect of thyroid dysfunction on the elimination of beta-adrenoreceptor blocking drugs. Bell JM; Russell CJ; Nelson JK; Kelly JG; McDevitt DG Br J Clin Pharmacol; 1977 Feb; 4(1):79-82. PubMed ID: 14661 [No Abstract] [Full Text] [Related]
4. Effect of propranolol on extrathyroidal metabolism of thyroxine and 3,3',5-triiodothyronine evaluated by noncompartmental kinetics. Lumholtz IB; Siersbaek-Nielsen K; Faber J; Kirkegaard C; Friis T J Clin Endocrinol Metab; 1978 Sep; 47(3):587-9. PubMed ID: 263312 [TBL] [Abstract][Full Text] [Related]
13. Effects of age and cigarette smoking on propranolol disposition. Vestal RE; Wood AJ; Branch RA; Shand DG; Wilkinson GR Clin Pharmacol Ther; 1979 Jul; 26(1):8-15. PubMed ID: 445965 [No Abstract] [Full Text] [Related]
14. Cyclic adenosine 3',5'-monophosphate concentration in plasma, adipose tissue and skeletal muscle in normal subjects and in patients with hyper- and hypothyroidism. Karlberg BE; Henriksson KG; Andersson RG J Clin Endocrinol Metab; 1974 Jul; 39(1):96-101. PubMed ID: 4365918 [No Abstract] [Full Text] [Related]
15. Naphthoxylactic acid after single and long-term doses of propranolol. Walle T; Conradi EC; Walle UK; Fagan TC; Gaffney TE Clin Pharmacol Ther; 1979 Nov; 26(5):548-54. PubMed ID: 498695 [No Abstract] [Full Text] [Related]
16. Plasma protein binding of propranolol and isoprenaline in hyperthyroidism and hypothyroidism. Kelly JG; McDevitt DG Br J Clin Pharmacol; 1978 Aug; 6(2):123-7. PubMed ID: 678388 [TBL] [Abstract][Full Text] [Related]
17. Hemodynamic and pharmacokinetic study of propranolol and atenolol in cirrhosis patients. Rocher I; Decourt S; Leneveu A; Lebrec D; Rosier SP; Flouvat B Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):406-10. PubMed ID: 4044073 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of a fixed combination with propranolol, hydrochlorothiazide and triamterene. Felder K; Geissler HE; Hiemstra S; Mutschler E; Schäfer M; Ziegler E Arzneimittelforschung; 1979; 29(11):1746-52. PubMed ID: 543886 [TBL] [Abstract][Full Text] [Related]
19. Analysis and disposition of low dose oral propranolol. MacKichan JJ; Pyszczynski DR; Jusko WJ Res Commun Chem Pathol Pharmacol; 1978 Jun; 20(3):531-8. PubMed ID: 674830 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of SL 75212 and propranolol in old age, uraemia and in healthy young adults [proceedings]. Bianchetti G; Brancaccio D; Forette F; Henry JF; Hervy MP; Ganansia J; Gomeni R; Kilborn JR; Morselli PL Br J Clin Pharmacol; 1980 Mar; 9(3):299P. PubMed ID: 6102472 [No Abstract] [Full Text] [Related] [Next] [New Search]